News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Iframe sync Post navigation Previous: Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories Apps Fitness News Nutrition MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users Staff December 6, 2025 Healthcare News Pharmaceutical AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio Staff December 6, 2025 Cancer Diagnostics DNA Medicare News Patient Care Pharmaceutical Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting Staff December 6, 2025
